Semaglutide — the active substance in Ozempic and Wegovy — may help reduce alcohol cravings in people with alcohol use ...

It’s possible that GLP-1s may be useful for a range of substance use disorders, including opioid use disorder and nicotine ...

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

Semaglutide, known as Ozempic, may reduce alcohol cravings and consumption, offering new addiction treatment possibilities.

A breakthrough study reveals that semaglutide, found in Ozempic and Wegovy, could help reduce alcohol cravings and heavy ...

Clinical assessments also indicated that semaglutide (compared to placebo injections) reduced weekly alcohol craving, reduced average drinks on drinking days, and led to greater reductions in ...

A new study published in the journal JAMA Psychiatry found that semaglutide (sold under brand names like Ozempic and Wegovy) ...

Medications that have transformed the treatment of obesity may also help people drink less alcohol, according to new ...

Semaglutide, the active ingredient in Ozempic and Wegovy, could revolutionize the treatment of alcohol and tobacco-related ...

They also drank less each day, had less heavy drinking days, and reported fewer cravings for alcohol. Based on the findings, the researchers concluded that low doses of semaglutide “can reduce ...